Literature DB >> 7914901

Asp f I CD4+ TH2-like T-cell lines in allergic bronchopulmonary aspergillosis.

A P Knutsen1, K R Mueller, A D Levine, B Chouhan, P S Hutcheson, R G Slavin.   

Abstract

Allergic bronchopulmonary aspergillosis (ABPA) is a hypersensitivity lung disease caused by bronchial colonization with Aspergillus fumigatus (Af) characterized by elevated serum total and Af-specific IgE levels and eosinophilia. In order to examine T-cell reactivity to Af antigens, six T-cell lines were established from the peripheral blood of patients with ABPA to Asp f I, an 18 kd protein purified from Af extracts. The Asp f I-specific T-cell lines, analyzed by flow cytometry, were 100% CD3+ CD4+. Lymphoproliferative responses of the T-cell lines were specific for Asp f I stimulation, 28,999 cpm (stimulation index = 12.2), and showed no response to tetanus toxoid stimulation, 2178 cpm (stimulation index = 1.1) (p < 0.001). Furthermore, Asp f I-stimulated lymphoproliferation was inhibited in two experiments by monoclonal anti-interleukin (IL)-4 antibody in a dose-response fashion, 78% and 84% inhibition at 5% concentration of anti-IL-4. In contrast, anti-IL-2 antibody did not inhibit Asp f I-stimulated proliferation. Asp f I-stimulated T-cell lines synthesized predominantly IL-4 (mean, 21.5 ng/ml) after 48 hours of culture, and nondetectable quantities of interferon-gamma and IL-2. In summary, Asp f I-specific T-cell lines established from patients with ABPA were characterized as being CD4+ TH2-like in their cytokine synthesis pattern, and secreted IL-4 behaved in an autocrine fashion, stimulating proliferation.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7914901     DOI: 10.1016/0091-6749(94)90043-4

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  17 in total

Review 1.  Infectious disease, the innate immune response, and fibrosis.

Authors:  Alessia Meneghin; Cory M Hogaboam
Journal:  J Clin Invest       Date:  2007-03       Impact factor: 14.808

2.  Molecular biology and immunology of fungal allergens.

Authors:  V P Kurup; B Banerjee; K J Kelly; J N Fink
Journal:  Indian J Clin Biochem       Date:  2000-08

Review 3.  Type 1 and type 2 cytokine dysregulation in human infectious, neoplastic, and inflammatory diseases.

Authors:  D R Lucey; M Clerici; G M Shearer
Journal:  Clin Microbiol Rev       Date:  1996-10       Impact factor: 26.132

4.  Generation of cytotoxic T cell responses directed to human leucocyte antigen Class I restricted epitopes from the Aspergillus f16 allergen.

Authors:  G Ramadan; B Davies; V P Kurup; C A Keever-Taylor
Journal:  Clin Exp Immunol       Date:  2005-04       Impact factor: 4.330

Review 5.  Aspergillus fumigatus and aspergillosis.

Authors:  J P Latgé
Journal:  Clin Microbiol Rev       Date:  1999-04       Impact factor: 26.132

6.  A comparison between intratracheal and inhalation delivery of Aspergillus fumigatus conidia in the development of fungal allergic asthma in C57BL/6 mice.

Authors:  Amali E Samarasinghe; Scott A Hoselton; Jane M Schuh
Journal:  Fungal Biol       Date:  2010-10-08

7.  Th1 and Th2 cytokines in mice with invasive aspergillosis.

Authors:  E Cenci; S Perito; K H Enssle; P Mosci; J P Latgé; L Romani; F Bistoni
Journal:  Infect Immun       Date:  1997-02       Impact factor: 3.441

Review 8.  Allergic bronchopulmonary aspergillosis.

Authors:  Richard B Moss
Journal:  Clin Rev Allergy Immunol       Date:  2002-08       Impact factor: 8.667

Review 9.  Fungus-Specific CD4 T Cells as Specific Sensors for Identification of Pulmonary Fungal Infections.

Authors:  Alexander Scheffold; Carsten Schwarz; Petra Bacher
Journal:  Mycopathologia       Date:  2017-11-22       Impact factor: 2.574

10.  T cell subsets, epitope mapping, and HLA-restriction in patients with allergic bronchopulmonary aspergillosis.

Authors:  B Chauhan; A p Knutsen; P S Hutcheson; R G Slavin; C J Bellone
Journal:  J Clin Invest       Date:  1996-05-15       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.